切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2019, Vol. 13 ›› Issue (06) : 567 -570. doi: 10.3877/cma.j.issn.1674-3946.2019.06.009.

所属专题: 文献

论著

肝泡型包虫病临床路径实施效果评价
段帅1, 吐尔干艾力·阿吉1, 蒋铁民1, 冉博1, 郭强1, 邵英梅1,()   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院消化血管中心肝胆包虫科
  • 收稿日期:2019-04-04 出版日期:2019-12-26
  • 通信作者: 邵英梅

Evaluation of clinical pathway in the therapeutic treatment hepatic alveolar echinococcosis

shuai Duan1, Aji Tuerganaili·1, Tiemin Jiang1, Bo Ran1, Qiang Guo1, Yingmei Shao1,()   

  1. 1. Department of hepatobiliary hydatidosis surgery, digestive and vascular surgery center, the First Affiliated Hospital of Xinjiang Medical University, Xinjiang 830054, China
  • Received:2019-04-04 Published:2019-12-26
  • Corresponding author: Yingmei Shao
  • About author:
    Corresponding author: Shao Yingmei, Email:
  • Supported by:
    Key discipline (Peak discipline) of the 13th-five-year plan of the Autonomous Region(new teaching and Research (2016) No.7); National Natural Science Foundation of China(NO.81560098)
引用本文:

段帅, 吐尔干艾力·阿吉, 蒋铁民, 冉博, 郭强, 邵英梅. 肝泡型包虫病临床路径实施效果评价[J/OL]. 中华普外科手术学杂志(电子版), 2019, 13(06): 567-570.

shuai Duan, Aji Tuerganaili·, Tiemin Jiang, Bo Ran, Qiang Guo, Yingmei Shao. Evaluation of clinical pathway in the therapeutic treatment hepatic alveolar echinococcosis[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2019, 13(06): 567-570.

目的

评价肝泡型包虫病(HAE)临床路径(CP)的实施效果。

方法

回顾性分析并比较纳入临床路径诊治的84例(CP组)和未纳入临床路径诊治的86例(非CP组) HAE病患者临床疗效。运用SPSS 19.0统计软件进行数据分析,术后各项指标以(±s)表示,独立t检验;术后并发症发生率采用χ2检验。以P<0.05为差异有统计学意义。

结果

CP组患者的住院时间(10.9±1.3) d和住院费用(3.5±0.3)万元低于非CP组[(14.1±1.2) d、(3.8±0.4)万元],P<0.05;CP组患者的满意度更高、出院时包虫病健康知识掌握情况亦优于非CP组(P<0.05)。两组患者在术后并发症发生情况方面差异无统计学意义(P>0.05)。

结论

实施HAE临床路径可有效缩短患者住院时间,降低诊疗费用、减轻患者经济负担,对提升患者满意度、普及包虫病健康知识具有积极作用,值得临床应用和推广,但临床路径的变异发生率较高,需要及时进行干预与不断优化管理以适用于临床。

Objective

To evaluate the effect of clinical pathway (CP) in the therapeutic treatment hepatic alveolar echinococcosis (HAE).

Methods

The clinical data were analyzed retrospectively, including 84 patients in CP group and 86 patients in non-CP group. Statistical analysis was performed by using SPSS 19.0 software. Measurement data were expressed as mean±standard deviation and were examined by independent t test. Count data such as the incidence of postoperative complications were described by (n, %) and were examined by chi square test. The correlation between predicted resected liver volume and actual resected liver volume were also analyzed. A P value of <0.05 was considered as statistically significant.

Results

The hospitalization time of (10.9±1.3) d and hospitalization expenses of (35±3) thousand yuan in the CP group were significantly lower than (14.1±1.2) d and (38±4) thousand yuan in the non-CP group respectively, P<0.05; The patient’s satisfaction in CP group was higher, and the knowledge of echinococcosis health at discharge was better than those in non-CP group respectively (P<0.05). There was no significant difference in the incidence of postoperative complications between the two groups (P>0.05).

Conclusion

Implementing the clinical pathway of HAE could effectively shorten the hospitalization time, reduce the cost of treatment as well as the economic burden of patients, and has a positive effect on improving patient satisfaction and popularizing the health knowledge of echinococcosis. It is worthy of clinical application and promotion, but the incidence of mutations in the clinical pathway is high, requiring timely intervention and continuous optimization management for clinical use.

表1 170例HAE患者不同临床路径两组一般情况比较(例)
表2 170例HAE患者不同临床路径两组患者术后各项指标比较(±s)
表3 170例HAE患者不同临床路径两组患者术后并发症比较(例)
[1]
Vuitton DA, Zhou H, Bresson-Hadni S,et al. Epidemiology of alveolar echinococcosis with particular reference to China and Europe[J]. Parasitology,2003,127 Suppl: S87-S107.
[2]
毕建斌,庞青,王志鑫,等.肝泡型包虫病138例的临床特征与手术疗效[J].中华消化杂志,2016,36(9): 629-632.
[3]
蒋铁民,吐尔干艾力,邵英梅,等.肝囊型包虫病临床路径的应用效果分析[J].中华肝胆外科杂志,2013,19(12): 912-915.
[4]
Lawal AK, Rotter T, Kinsman L,et al.What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review[J]. BMC Med,2016,14: 35-35.
[5]
中国医师协会外科医师分会包虫病外科专业委员会.肝两型包虫病诊断与治疗专家共识(2015版)[J].中华消化外科杂志,2015,14(4): 253-264.
[6]
Koch M, Garden OJ, Padbury R,et al.Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery[J].Surgery,2011,149(5): 680-688.
[7]
Balzan S, Belghiti J, Farges O,et al.The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy[J].Ann Surg,2005,242(6): 824-829.
[8]
Yucel Y, Seker A, Eser I,et al.Surgical treatment of hepatic hydatid cystsA retrospective analysis of 425 patients[J]. Ann Ital Chir,2015,86: 437-443.
[9]
邵军,王志鑫,阳丹才让,等.青藏高原地区泡型包虫病患者住院费用影响因素分析[J].中华疾病控制杂志,2018,22(2): 168-172.
[10]
Vanhaecht K.Prevalence and use of clinical pathways in 23 countries: an international survey by the European Pathway Association[J]. Int J Care Pathways,2006,10(1): 28-34.
[11]
Alberta Health Services.Diabetes foot care clinical pathway development project[EB/OL]. [2017-02-21].

URL    
[12]
中华人民共和国国家卫生和计划生育委员会.全国临床路径管理试点工作总结评估情况[EB/OL].[2016-11-22].

URL    
[13]
Dong W, Huang Z.A Method to Evaluate Critical Factors for Successful Implementation of Clinical Pathways[J].Appl Clin Inform,2015,6(4): 650-668.
[14]
Rankin NM, Butow PN, Thein T,et al.Everybody wants it done but nobody wants to do it: an exploration of the barrier and enablers of critical components towards creating a clinical pathway for anxiety and depression in cancer[J]. BMC Health Serv Res,2015,15: 28-28.
[15]
Julia Neuberger RB.The Liverpool Care Pathway: what went right andwhat went wrong[J]. Br J Hosp Med(Lond),2016,77(3): 172-174.
[1] 潘韩丽, 何静, 陈媛媛, 贾梦瑶, 赵兴, 杨佩. 机器人辅助全髋关节置换围手术期应用加速康复护理[J/OL]. 中华关节外科杂志(电子版), 2024, 18(01): 142-146.
[2] 盛志强, 袁嫣然. ATP1A3基因突变相关疾病1个家系报道及文献复习[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 331-338.
[3] 张雪灵, 陈玮彬, 魏雯硕, 陈明, 诸宏伟. 努南综合征的临床特点与治疗效果分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 192-199.
[4] 董晓燕, 赵琪, 唐军, 张莉, 杨晓燕, 李姣. 奥密克戎变异株感染所致新型冠状病毒感染疾病新生儿的临床特征分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 595-603.
[5] 张阳, 纽燕娜, 常丽蓉, 唐国华, 赵萍. ERAS理念下肝棘球蚴病术后并发症风险预测模型构建[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 287-290.
[6] 索郎多杰, 高红桥, 巴桑顿珠, 仁桑. 腹腔镜下不同术式治疗肝囊型包虫病的临床疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(06): 670-673.
[7] 杨智義, 赵成俊, 胡欣芫, 潘佰猛, 张秋雨, 张挽乾, 曹芮, 张灵强. 外周血cfDNA液体活检技术在肝棘球蚴病诊治中的应用进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 389-393.
[8] 费发珠, 张帅, 刘发蓉, 芦佳骏, 任宾, 樊海宁. 三维可视化联合术中ICG荧光引导腹腔镜肝包虫病切除术一例[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 577-580.
[9] 王建奇, 陈政良, 刘雨, 俞星新, 耿志达, 姜洪池, 梁英健. 基于160例患者CT三维重建的肝血管解剖变异分析[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 427-433.
[10] 李金星, 陈志宏, 孙铭均, 孙岩岩, 党树伟, 李广恩, 彭书奇, 付大伟, 李宏伟, 李国东. 基于多层螺旋CT 的腹腔干解剖变异与新分型研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 756-763.
[11] 李瑞琦, 吴子健, 吴杰斌, 任佳佳, 翟敬芳. 动脉血气分析判读Excel电子表格在实习生酸碱平衡紊乱教学中的应用[J/OL]. 中华临床医师杂志(电子版), 2023, 17(06): 737-743.
[12] 陶莹, 李晓光, 朱桃红, 杨彦, 陈琦. Westgard西格玛规则在中孕期母血清学产前筛查质量管理中的应用[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(02): 65-69.
[13] 裴世静, 万艳红, 刘金萍, 高奇, 马斌国. 山西省全血细胞计数室间质量评价不同分析性能规范的应用探讨[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(01): 16-21.
[14] 徐来英, 程效, 戴亨纷, 侯俊凉, 苏怡林, 张彦. 药物联合个体化精准恒定功率运动疗法治疗心肌梗死术后频发室性早搏一例[J/OL]. 中华心脏与心律电子杂志, 2024, 12(03): 176-179.
[15] 杨海华, 袁景林, 周晓梅, 牛军伟. RNF213基因突变所致烟雾病一家系病例临床分析并文献复习[J/OL]. 中华脑血管病杂志(电子版), 2023, 17(05): 495-498.
阅读次数
全文


摘要